Latest News- Animal Biotechnology Market: Drugs is expected to lead the Product segment during 2025-2029

The Animal Biotechnology Market is being driven by Increasing growth strategies of market players

The Animal Biotechnology Market is expected to grow at a CAGR of 3.3% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 4465.1 million. In the animal health industry, biotechnology products offer significant value through their application in the diagnosis, treatment, and management of various animal diseases. These include conditions such as osteoarthritis, leptospirosis, Foot-and-Mouth Disease (FMD), salmonella, swine fever, avian influenza, and Bovine Respiratory Disease (BRD). The increasing incidence of animal diseases is projected to fuel demand for effective solutions in the form of drugs, vaccines, and diagnostic tests. For instance, osteoarthritis, a common condition in aging companion animals like cats and dogs, affects around 60% of felines older than six years and 90% of those over 12. Current treatment options for feline osteoarthritis pain are often inadequate due to safety and efficacy concerns over long-term usage. 

Get more information on Animal Biotechnology Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Product
  • Drugs
  • Vaccines
  • Diagnostic tests
  • Others
• Animal Type
  • Livestock/production
  • Companion
• Technology
  • CRISPR-Cas9
  • Gene transfer
  • Genome editing
  • RNA interference
  • Nanotechnology
• Product Type
  • Cloning services
  • Embryo biotechnology
  • Gene editing
  • In vitro fertilization (IVF)
  • Marker assisted selection (MAS)
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
  • Asia
    • China
    • India
    • Japan
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Increasing growth strategies of market players
• Growing focus on animal cloning
• Use of transgenic animals to produce recombinant proteins

However, the market also witnesses some limitations, which are as follows:

• Lack of skilled workforce to perform diagnostic tests
• Ethical issues associated with animal biotechnology products
• Practical challenges associated with behavioral studies of animals

Benefits of Buying Global Animal Biotechnology Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Animal Biotechnology Market Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

Animal biotechnology encompasses various applications of genetic engineering, cloning, transgenesis, and reproductive technologies in the fields of animal health, medicine, and production. This includes the development of pharmaceuticals for cancer treatment and osteoarthritis, as well as vaccines and diagnostic tests for zoonotic diseases. The genetic composition and physiology of animals are key areas of study, with a focus on improving animal health, animal-based goods, and animal derived products. The animal feed sector also benefits from advances in molecular biology and immunology, aiming for increased efficiency in animal agriculture. Public health systems and human medicine can also benefit from animal biotechnology, with applications in drug development for various conditions such as cancer and bovine spongiform encephalopathy. Animals such as dogs and cats are also subjects of research in this field, with potential applications in animal health and the production of therapeutic proteins.

Market Research Overview

In the realm of global biotechnology, the animal biotech sector represents a significant segment within the larger market. This sector encompasses businesses specializing in research and development (R&D) or production of genetically engineered animals, cloning, transgenesis, reproductive technologies, and animal health solutions. These innovations leverage genetic composition, physiology, medicine, and technology to enhance animal productivity, improve animal health, and develop new pharmaceutical applications. The burgeoning healthcare market, a key component of the global biotechnology industry, is poised for substantial expansion. According to market research firm Technavio, this growth is attributable to several factors, including the increasing aging population. By 2050, approximately one-quarter of the US population and a similar proportion in Europe are projected to be over 60 years old. This demographic shift will fuel demand for healthcare products and services, including those derived from animal biotechnology.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/